Clinical and inflammatory features of occupational asthma caused by persulphate salts in comparison with asthma associated with occupational rhinitis von Moscato, G, Pala, G, Perfetti, L, Frascaroli, M, Pignatti, P

Volltext

Comorbidity scores as predictive tools for nivolumab toxicity in patients with advanced non small cell lung cancer (NSCLC): preliminary results of a prospective multicenter study von Quaquarini, E., Sottotetti, F., Palumbo, R., Gambaro, A., Ferzi, A., Frascaroli, M., Teragni, C., Tagliaferri, B., Pozzi, E., Licata, L., Massa, G., Bernardo, A.

Volltext

New insights on the mechanism of oxidation of D-galacturonic acid by hypervalent chromium von Mangiameli, M F, González, J C, García, S I, Frascaroli, M I, Van Doorslaer, S, Salas Peregrin, J M, Sala, L F

Volltext

455P Post progression treatments after endocrine therapy (ET) plus palbociclib in patients with HR+/HER2- metastatic breast cancer (MBC): A prospective, real-world study von Palumbo, R., Saltalamacchia, G., Quaquarini, E., Tagliaferri, B., Teragni, C.M., Barletta, C., Frascaroli, M., Biscaldi, E., Malovini, A., Locati, L.D., Sottotetti, F.

Volltext

Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities von Catalano, Oronzo, Antonaci, Serena, Moro, Guido, Mussida, Maria, Frascaroli, Mauro, Baldi, Maurizia, Cobelli, Franco, Baiardi, Paola, Nastoli, Janni, Bloise, Raffaella, Monteforte, Nicola, Napolitano, Carlo, Priori, Silvia G.

Volltext

Factors affecting recurrence risk in her2 positive dcis von Di Cesare, P., Pavesi, L., Villani, L., Frascaroli, M.

Volltext

64PPost-progression evaluation of patients treated with nivolumab for advanced non-small cell lung cancer: A prospective cohort analysis von Quaquarini, E, Gervaso, L, Sottotetti, F, Bernardo, A, Palumbo, R, Gambaro, A, Frascaroli, M, Tagliaferri, B, Teragni, C M, Presti, D, Porta, C

Volltext

Post-progression evaluation of patients treated with nivolumab for advanced non-small cell lung cancer: A prospective cohort analysis von Quaquarini, E., Gervaso, L., Sottotetti, F., Bernardo, A., Palumbo, R., Gambaro, A., Frascaroli, M., Tagliaferri, B., Teragni, C.M., Presti, D., Porta, C.

Volltext

3039Vulnerability of carotid atherosclerosis: relationship with plaque location, plaque eccentricity and vessel remodeling patterns. Insight from the the MAGNETIC observational stu... von Catalano, O, Cerabolini, C, Eshja, E, Bendotti, G, De Salvo, M, Aloi, T L, Ferrari Bardile, A, Frascaroli, M, Zanaboli, D, Tibollo, V, Bellazzi, R, Poggi, P, Pedretti, R F E

Volltext

Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group von Apolone, G, Corli, O, Caraceni, A, Negri, E, Deandrea, S, Montanari, M, Greco, M T

Volltext

5174 Predictive factors of response to neoadjuvant 3-weekly epirubicin (EPI) plus docetaxel (DOC) chemotherapy (CT) in locally advanced breast cancer (LABC): a prospective phase II... von Strada, M.R, Frascaroli, M, Palumbo, R, Bernardo, A, Villani, L, Scelsi, M, Jedrychowska, I, Albanese, D, Teragni, C, Bernardo, G

Volltext

Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports von Giordano, Guido, Febbraro, Antonio, Quaquarini, Erica, Turletti, Anna, Pedersini, Rebecca, Raffaele, Mimma, Villa, Federica, Rossello, Rosalba

Volltext

5081 Triple combination of 3-weekly trastuzumab (T) plus oral vinorelbine (VNR) and capecitabine (CAP) as first-line treatment in HER2-positive metastatic breast cancer (MBC): an a... von Palumbo, R, Bernardo, A, Strada, M.R, Poggi, G, Teragni, C, Amatu, A, Frascaroli, M, Montagna, B, Sottotetti, F, Bernardo, G

Volltext

Activity and safety of vinorelbine and capecitabine as first-line treatment in patients with metastatic breast cancer – a phase II trial von Palumbo, R, Bernardo, A, Strada, M, Teragni, C, Poggi, G, Frascaroli, M, Amatu, A, Palumbo, I, Bernardo, G

Volltext

Factors affecting occupational returning in breast cancer survivors in working age: preliminary analysis from a 131-patient sample von Strada, M, Frascaroli, M, Jedrychowska, I, Innaurato, C, Bernardo, A, Palumbo, R, Poggi, G, Teragni, C, Amatu, A, Bernardo, G

Volltext

Trastuzumab plus intravenous or oral vinorelbine in chemonaive patients with HER-2 overexpressing metastatic breast cancer – final results of an extended phase II trial von Bernardo, G, Palumbo, R, Bernardo, A, Teragni, C, Poggi, G, Delmonte, A, Amatu, A, Frascaroli, M, Jedrychowska, I, Strada, M

Volltext

Abstract P2-14-05: Is It Only a Question of Willpower? Factors Associated with Job Resumption after Primary Breast Cancer Treatment — A Prospective Mono-Centre Trial von Strada, MR, Palumbo, R, Frascaroli, M, Albanese, D, Poggi, G, Bernardo, A, Amatu, A, Teragni, C, Jedrychowska, I, Malagò, G, Petracca, M, Bernardo, G.

Volltext

Abstract P6-11-03: Beyond the Second Line Chemotherapy in Metastatic Breast Cancer: When Stop the Treatment between Science and Conscience von Bernardo, G, Palumbo, R, Poggi, G, Bernardo, A, Teragni, C, Frascaroli, M, Amatu, A, Montagna, B, Tagliaferri, B, Sottotetti, F, Albanese, D, Strada, MR

Volltext

Oxidation of l-rhamnose and d-mannose by chromium(VI) in aqueous acetic acid von Rizzotto, M., Frascaroli, M.I., Signorella, S., Sala, L.F.

Volltext

Palonosetron compared to ondansetron in the prevention of chemotherapy-induced nausea and vomiting: Activity, safety, and cost-effectiveness evaluation von Bernardo, G., Palumbo, R., Frascaroli, M., Bernardo, A., Losurdo, A., Poggi, G., Teragni, C., Albanese, D., Amatu, A., Strada, M. R.

Volltext